Infosys:Differentiated AI strategy and a sharp focus on value unlock propels 29% sequential growth in AI revenues

Infosys reported Q2 revenue of $5.145 billion, up 1.5% year over year and 1.2% sequentially in constant currency, with operating margin stable at 21.0%; net profit after non-controlling interests fell to $817 million from $839 million a year earlier. AI revenue was 10.5% of revenue and grew 29% quarter over quarter, while large-deal TCV reached $5.2 billion, 62% net new. The company set FY27 constant-currency revenue growth guidance at 1%-2% and retained its 20%-22% margin range; its board announced an interim dividend of ₹26 per share, up 13% from last year.

Analysis

The key tension is weak near-term demand against encouraging but unproven indicators of future work. Large-deal TCV is not recognized revenue: conversion timing, ramp-up, cancellations and pricing determine whether bookings lift growth. A mega-deal also raises execution and concentration risk. The reported AI revenue growth is strategically positive, but the 10.5% revenue share needs a consistent definition and evidence of incremental, higher-value economics; AI could also automate billable work and pressure labor-based pricing. The 1%-2% FY27 growth outlook therefore matters more than the AI narrative until bookings convert into revenue acceleration.

For the next few days, the release may support sentiment through stable margins, cash generation and the dividend, but it does not establish a near-term earnings re-rating. Over 1-3 months, track deal conversion, discretionary client spending and whether guidance is raised or cut. Over 6-18 months, scaled AI delivery could differentiate Infosys from Accenture, Cognizant, Tata Consultancy Services and Wipro—but may also cannibalize labor-linked revenue. Client announcements are not independent proof of material contract economics. Microsoft, Salesforce, ServiceNow and Oracle may participate in enterprise AI deployments, but these wins alone do not establish incremental revenue for those vendors.

Contrarian angle: investors may overvalue AI growth from a potentially small base, while underweighting the option value of net-new bookings and operational leverage if demand recovers. The thesis fails on sustained growth acceleration and upward guidance revisions; it strengthens if bookings fail to convert or guidance is reduced. Valuation and consensus data are not provided, so avoid an unconditional directional call.

Key Decisions for Investors

• Do not chase the AI headline alone. Verify how Infosys defines AI revenue, its share of total revenue over time, and whether AI work is incremental or replacing existing billable services.
• Treat the large-deal figure as a pipeline indicator, not an earnings forecast. Monitor quarterly revenue conversion, net-new deal composition and any disclosed ramp or cancellation information over the next 1-3 months.
• Relative-value watch: if Infosys rallies on the release without improving growth guidance or conversion metrics, consider a small short or underweight versus a diversified IT-services peer basket; cap risk and reassess on a guidance upgrade. No valuation or price data are supplied to set an entry level.
• For customers and ecosystem exposure, do not infer material upside for CROX, MDLZ, MSFT, CRM, NOW, ORCL, KBX, INVP or TELIA from the announcements alone; seek contract scale, implementation timing and measurable savings before changing positions.